vs
Side-by-side financial comparison of Phathom Pharmaceuticals, Inc. (PHAT) and SYPRIS SOLUTIONS INC (SYPR). Click either name above to swap in a different company.
Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $30.3M, roughly 1.9× SYPRIS SOLUTIONS INC). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs -9.5%). SYPRIS SOLUTIONS INC produced more free cash flow last quarter ($-1.5M vs $-167.0M).
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
Sypris Solutions Inc. is a U.S.-headquartered provider of highly engineered components and specialized technical services, primarily serving aerospace, defense, automotive and commercial industrial markets. It delivers custom manufacturing, performance testing, and value-added engineering support for mission-critical systems and parts for global enterprise clients.
PHAT vs SYPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $57.6M | $30.3M |
| Net Profit | — | $-3.9M |
| Gross Margin | 86.7% | 4.6% |
| Operating Margin | — | -10.9% |
| Net Margin | — | -12.9% |
| Revenue YoY | 94.1% | -9.5% |
| Net Profit YoY | 71.6% | -2992.6% |
| EPS (diluted) | — | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $57.6M | $30.3M | ||
| Q3 25 | $49.5M | $28.7M | ||
| Q2 25 | $39.5M | $31.4M | ||
| Q1 25 | $28.5M | $29.5M | ||
| Q4 24 | $29.7M | $33.4M | ||
| Q3 24 | $16.4M | $35.7M | ||
| Q2 24 | $7.3M | $35.5M | ||
| Q1 24 | — | $35.6M |
| Q4 25 | — | $-3.9M | ||
| Q3 25 | $-30.0M | $517.0K | ||
| Q2 25 | $-75.8M | $-2.1M | ||
| Q1 25 | $-94.3M | $-899.0K | ||
| Q4 24 | — | $135.0K | ||
| Q3 24 | $-85.6M | $390.0K | ||
| Q2 24 | $-91.4M | $16.0K | ||
| Q1 24 | — | $-2.2M |
| Q4 25 | 86.7% | 4.6% | ||
| Q3 25 | 87.5% | 7.2% | ||
| Q2 25 | 87.2% | 8.2% | ||
| Q1 25 | 86.9% | 11.4% | ||
| Q4 24 | 87.1% | 16.1% | ||
| Q3 24 | 85.6% | 16.8% | ||
| Q2 24 | 81.2% | 15.9% | ||
| Q1 24 | — | 8.1% |
| Q4 25 | — | -10.9% | ||
| Q3 25 | -30.8% | -6.1% | ||
| Q2 25 | -151.7% | -4.6% | ||
| Q1 25 | -276.5% | -0.4% | ||
| Q4 24 | — | 3.9% | ||
| Q3 24 | -433.0% | 4.8% | ||
| Q2 24 | -1055.4% | 3.6% | ||
| Q1 24 | — | -3.9% |
| Q4 25 | — | -12.9% | ||
| Q3 25 | -60.5% | 1.8% | ||
| Q2 25 | -191.9% | -6.5% | ||
| Q1 25 | -330.7% | -3.0% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | -523.3% | 1.1% | ||
| Q2 24 | -1248.6% | 0.0% | ||
| Q1 24 | — | -6.2% |
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $-0.41 | $0.02 | ||
| Q2 25 | $-1.05 | $-0.09 | ||
| Q1 25 | $-1.31 | $-0.04 | ||
| Q4 24 | — | $0.00 | ||
| Q3 24 | $-1.32 | $0.02 | ||
| Q2 24 | $-1.56 | $0.00 | ||
| Q1 24 | — | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $130.0M | — |
| Total DebtLower is stronger | $209.1M | — |
| Stockholders' EquityBook value | $-438.2M | $17.8M |
| Total Assets | $259.1M | $107.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $130.0M | — | ||
| Q3 25 | $135.2M | — | ||
| Q2 25 | $149.6M | — | ||
| Q1 25 | $212.3M | — | ||
| Q4 24 | $297.3M | — | ||
| Q3 24 | $334.7M | — | ||
| Q2 24 | $276.2M | — | ||
| Q1 24 | — | — |
| Q4 25 | $209.1M | — | ||
| Q3 25 | $207.1M | — | ||
| Q2 25 | $205.1M | — | ||
| Q1 25 | $203.2M | — | ||
| Q4 24 | $201.4M | — | ||
| Q3 24 | $175.7M | — | ||
| Q2 24 | $174.4M | — | ||
| Q1 24 | — | — |
| Q4 25 | $-438.2M | $17.8M | ||
| Q3 25 | $-422.5M | $20.0M | ||
| Q2 25 | $-405.8M | $18.7M | ||
| Q1 25 | $-338.4M | $19.0M | ||
| Q4 24 | $-253.6M | $19.6M | ||
| Q3 24 | $-187.1M | $18.2M | ||
| Q2 24 | $-233.8M | $19.0M | ||
| Q1 24 | — | $20.8M |
| Q4 25 | $259.1M | $107.8M | ||
| Q3 25 | $240.3M | $112.5M | ||
| Q2 25 | $250.2M | $105.8M | ||
| Q1 25 | $294.2M | $110.2M | ||
| Q4 24 | $378.3M | $119.4M | ||
| Q3 24 | $387.0M | $121.6M | ||
| Q2 24 | $319.4M | $124.2M | ||
| Q1 24 | — | $129.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-166.8M | $-1.1M |
| Free Cash FlowOCF − Capex | $-167.0M | $-1.5M |
| FCF MarginFCF / Revenue | -290.0% | -5.0% |
| Capex IntensityCapex / Revenue | 0.4% | 1.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-328.9M | $-6.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-166.8M | $-1.1M | ||
| Q3 25 | $-14.1M | $-178.0K | ||
| Q2 25 | $-62.7M | $1.1M | ||
| Q1 25 | $-84.9M | $-5.5M | ||
| Q4 24 | $-266.8M | $2.3M | ||
| Q3 24 | $-63.6M | $-4.8M | ||
| Q2 24 | $-70.7M | $6.2M | ||
| Q1 24 | — | $-1.7M |
| Q4 25 | $-167.0M | $-1.5M | ||
| Q3 25 | $-14.1M | $-390.0K | ||
| Q2 25 | $-62.8M | $941.0K | ||
| Q1 25 | $-84.9M | $-5.5M | ||
| Q4 24 | $-266.9M | $1.9M | ||
| Q3 24 | $-63.6M | $-4.9M | ||
| Q2 24 | $-70.8M | $6.0M | ||
| Q1 24 | — | $-2.0M |
| Q4 25 | -290.0% | -5.0% | ||
| Q3 25 | -28.6% | -1.4% | ||
| Q2 25 | -159.0% | 3.0% | ||
| Q1 25 | -297.9% | -18.8% | ||
| Q4 24 | -899.8% | 5.7% | ||
| Q3 24 | -389.0% | -13.8% | ||
| Q2 24 | -966.2% | 16.8% | ||
| Q1 24 | — | -5.7% |
| Q4 25 | 0.4% | 1.3% | ||
| Q3 25 | 0.1% | 0.7% | ||
| Q2 25 | 0.2% | 0.5% | ||
| Q1 25 | 0.1% | 0.0% | ||
| Q4 24 | 0.5% | 1.2% | ||
| Q3 24 | 0.3% | 0.4% | ||
| Q2 24 | 0.6% | 0.5% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 17.13× | ||
| Q3 24 | — | -12.21× | ||
| Q2 24 | — | 385.25× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PHAT
Segment breakdown not available.
SYPR
| Sypris Electronics | $17.7M | 59% |
| Transferred At Point In Time | $12.5M | 41% |
